These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16927582)

  • 1. Patterns of early adherence to the antidepressant citalopram among older primary care patients: the prospect study.
    Bogner HR; Lin JY; Morales KH
    Int J Psychiatry Med; 2006; 36(1):103-19. PubMed ID: 16927582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk.
    Gallo JJ; Hwang S; Joo JH; Bogner HR; Morales KH; Bruce ML; Reynolds CF
    J Gen Intern Med; 2016 Apr; 31(4):380-6. PubMed ID: 26432693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
    Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
    Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention to side effects enhances medical adherence.
    Vinberg M
    Acta Psychiatr Scand; 2007 Jan; 115(1):82. PubMed ID: 17201871
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.
    Cantrell CR; Eaddy MT; Shah MB; Regan TS; Sokol MC
    Med Care; 2006 Apr; 44(4):300-3. PubMed ID: 16565629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicide risk and choice of antidepressant.
    Davis A; Gilhooley M; Agius M; Zaman R
    Psychiatr Danub; 2010 Jun; 22(2):358-9. PubMed ID: 20562782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
    Perlis RH; Uher R; Perroud N; Fava M
    J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram: efficacy and tolerability in the treatment of depression.
    Baldwin DS
    Hosp Med; 2002 Nov; 63(11):668-71. PubMed ID: 12474611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
    McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distressing adverse events after antidepressant switch in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: influence of adverse events during initial treatment with citalopram on development of subsequent adverse events with an alternative antidepressant.
    Katz AJ; Dusetzina SB; Farley JF; Ellis AR; Gaynes BN; Castillo WC; Stürmer T; Hansen RA
    Pharmacotherapy; 2012 Mar; 32(3):234-43. PubMed ID: 22392456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in patients' beliefs about their antidepressant during the acute phase of depression treatment.
    Aikens JE; Klinkman MS
    Gen Hosp Psychiatry; 2012; 34(3):221-6. PubMed ID: 22325627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.
    Bruce ML; Ten Have TR; Reynolds CF; Katz II; Schulberg HC; Mulsant BH; Brown GK; McAvay GJ; Pearson JL; Alexopoulos GS
    JAMA; 2004 Mar; 291(9):1081-91. PubMed ID: 14996777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of citalopram in adolescents with depression.
    Bostic JQ; Prince J; Brown K; Place S
    J Child Adolesc Psychopharmacol; 2001; 11(2):159-66. PubMed ID: 11436955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
    Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction. Overview of citalopram.
    Lippa AS; Beer B; Cancro R
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):1S-3S. PubMed ID: 10507504
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy.
    Hochstrasser B; Isaksen PM; Koponen H; Lauritzen L; Mahnert FA; Rouillon F; Wade AG; Andersen M; Pedersen SF; Swart JC; Nil R
    Br J Psychiatry; 2001 Apr; 178():304-10. PubMed ID: 11282808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development of citalopram.
    Willetts J; Lippa A; Beer B
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):36S-46S. PubMed ID: 10507507
    [No Abstract]   [Full Text] [Related]  

  • 20. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.